ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT03821246 updates: 1. completion date: 2026-04-30 → 2027-04-30 2. primary completion date: 2026-04-30 → 2027-04-30
NOVO NORDISK A S (NVO)
Clinical trial NCT07566390: status: NOT_YET_RECRUITING → RECRUITING.
NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT06346483 updates: 1. completion date: 2026-06-09 → 2026-09-30 2. primary completion date: 2026-04-30 → 2026-08-30
PFIZER INC (PFE)
Clinical trial NCT05477524: completion date: 2026-02-06 → 2026-01-07.
SAREPTA THERAPEUTICS, INC. (SRPT)
Clinical trial NCT07536061 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-05 → 2026-05-12
ORTHOFIX MEDICAL INC. (OFIX)
Clinical trial NCT07282067 updates: 1. completion date: 2026-03-01 → 2026-06-30 2. primary completion date: 2026-03-01 → 2026-06-30
ASTRAZENECA PLC (AZN)
Clinical trial NCT04960709: primary completion date: 2026-04-30 → 2026-03-02.
NOVARTIS AG (NVSEF)
Clinical trial NCT07443137: start date: 2026-05-01 → 2026-07-01.
GRIFOLS SA (GIKLY)
Clinical trial NCT03702920 updates: 1. start date: 2019-02-21 → 2019-06-17 2. enrollment: 275 → 274 participants 3. collaborators removed: Instituto Grifols, S.A.
VIR BIOTECHNOLOGY, INC. (VIR)
Clinical trial NCT05997615: enrollment: 390 → 437 participants.